| Financial Year |
March 31 2023 |
| Monetary Funds |
626,150,585.55 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
973,641,631.84 |
| Advances to Suppliers |
23,461,169.47 |
| Other Receivables |
89,422,410.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
218,155,935.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,690,104.03 |
| Total Current Assets |
2,235,654,740.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,250,000.00 |
| Long-term Equity Investment |
37,011,366.86 |
| Investment Properties |
37,292,207.10 |
| Fixed Assetes |
5,308,608,579.74 |
| Under-construction Projects |
514,440,550.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,157,973,190.45 |
| R&D expenses |
-- |
| Goodwill |
14,617,574.60 |
| Long-Term Deferred and Prepaid Expenses |
2,859,763.80 |
| Deferred Income Tax Assets |
27,879,748.20 |
| Other Non-Current Assets |
6,388,619.54 |
| Sub-Total of Non-Current Assets |
12,294,129,085.36 |
| Total Assets |
14,529,783,826.12 |
| Short-Term Loans |
160,183,638.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,640,625.93 |
| Accounts Payable |
1,267,845,493.84 |
| Accounts Received In Advance |
911,190.00 |
| Employee Compensation Payable |
42,769,690.36 |
| Taxes Payable |
96,693,810.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
121,200,685.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
510,268,605.52 |
| Other Current Liabilities |
3,050,422.61 |
| Sub-Total of Current Liabilities |
2,235,028,951.86 |
| Long-term Loans |
4,034,444,952.13 |
| Bonds Payable |
1,216,450,615.87 |
| Long-Term Accounts Payable |
9,750,842.96 |
| Special Payable |
-- |
| Estimatied Liabilities |
326,952,268.37 |
| Deferred Income Tax Liabilities |
17,998,405.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,834,227,948.05 |
| Total Liabilities |
8,069,256,899.91 |
| Paid-In Capital(Or Share Stock) |
429,496,036.00 |
| Capital Surplus |
2,804,221,651.23 |
| Surplus Reserve |
181,223,428.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,692,998,313.49 |
| Minority Stockholder's Interest |
193,919,950.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,266,606,975.54 |
| Owner's Equity（Stockholder's Equity） |
6,460,526,926.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,529,783,826.12 |
